Showing results (751-760 of 2,229) with videos related to
Sort By:
Pageof 223
Cancer Biotherapy & Radiopharmaceuticals|November 25, 2003
Sterically stabilized etoposide liposomes: evaluation of antimetastatic activity and its potentiation by combination with sterically stabilized pentoxifylline liposomes in miceVinayak P Sant, M S Nagarsenker, S G Anand Rao, et al.Cancer Biotherapy & Radiopharmaceuticals|June 10, 2004
Role of 18F-FDG PET for evaluating malignant pleural mesotheliomaCristina Nanni, Paolo Castellucci, Mohsen Farsad, et al.Cancer Biotherapy & Radiopharmaceuticals|June 10, 2004
Functional imaging of multidrug resistant phenotype by 99mTc-MIBI scan in patients with multiple myelomaRosa Fonti, Silvana Del Vecchio, Antonella Zannetti, et al.Cancer Biotherapy & Radiopharmaceuticals|June 10, 2004
Radiolabeled carbohydrated somatostatin analogs: a review of the current statusHans-Jürgen Wester, Margret Schottelius, Thorsten Poethko, et al.Cancer Biotherapy & Radiopharmaceuticals|June 10, 2004
Clinical usefulness of 99mTc-EDDA/HYNIC-TOC scintigraphy in oncological diagnostics: a pilot studyAnna Plachcinska, Renata Mikolajczak, Helmut Maecke, et al.Cancer Biotherapy & Radiopharmaceuticals|February 11, 2021
E2F1-Induced FTH1P3 Promoted Cell Viability and Glycolysis Through miR-377-3p/LDHA Axis in Laryngeal Squamous Cell CarcinomaLina Zhao, Yi Zheng, Lei Zhang, et al.Cancer Biotherapy & Radiopharmaceuticals|September 25, 2019
Upregulation of SCNN1A Promotes Cell Proliferation, Migration, and Predicts Poor Prognosis in Ovarian Cancer Through Regulating Epithelial-Mesenchymal TransformationLan Wu, Zhong-Hui Ling, Huan Wang, et al.Cancer Biotherapy & Radiopharmaceuticals|October 24, 2018
Pretreatment CLR 124 Positron Emission Tomography Accurately Predicts CLR 131 Three-Dimensional Dosimetry in a Triple-Negative Breast Cancer PatientAbigail E Besemer, Joseph J Grudzinski, Jamey P Weichert, et al.Cancer Biotherapy & Radiopharmaceuticals|August 15, 2019
The Role of Kinase Signaling in Resistance to Bevacizumab Therapy for Glioblastoma MultiformeSara Ramezani, Nasim Vousooghi, Mohammad Taghi Joghataei, et al.Cancer Biotherapy & Radiopharmaceuticals|May 14, 2014
[(111)In-DTPA]octreotide tumor uptake in GEPNET liver metastases after intra-arterial administration: an overview of preclinical and clinical observations and implications for tumor radiation dose after peptide radionuclide therapyStefan E Pool, Boen L R Kam, Gerben A Koning, et al.Pageof 223